Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2021

Rabie Hatem, Othman Warda, Elsabaawy Dalia M, Elshemy Eman E, Abdelmageed Neamat, Khalaf Fatma A, Bedair Hanan M

Abstract excerpt

BACKGROUND: Portal vein thrombosis (PVT) might be a catastrophic event complicating liver cirrhosis and hepatocellular carcinoma (HCC). AIM: role of JAK2 RS V617F mutation as a risk factor for PVT development in liver cirrhosis and HCC. METHODS: A case control study conducted on 100 PVT patients (76 HCC and 24 liver cirrhosis) additionally, 100 healthy individuals used as a control group. PVT was diagnosed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Janus Kinase 2

Share to Liver Cirrhosis

Share to Liver Neoplasms

Share to Portal Vein

Share to Venous Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 33507708
DOI: 10.31557/APJCP.2021.22.1.267
PMCID: PMC8184185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma.PMID 33507708Read ↗

Novel insights into the development of portal vein thrombosis in cirrhosis patients.Semantic proximity Read ↗

Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis.Semantic proximity Read ↗

Portal vein thrombosis in patients with liver cirrhosis: Risk factors and clinical presentationSemantic proximity Read ↗

Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.Semantic proximity Read ↗

Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors.Semantic proximity Read ↗

Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis.Semantic proximity Read ↗

Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.Semantic proximity Read ↗

The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.Semantic proximity Read ↗

JAK2V617F mutation in patients with portal vein thrombosis.Semantic proximity Read ↗

Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.Semantic proximity Read ↗

Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.Semantic proximity Read ↗

Thrombophilic genetic factors PAI-1 4G-4G and MTHFR 677TT as risk factors of alcohol, cryptogenic liver cirrhosis and portal vein thrombosis, in a Caucasian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.